STOCK TITAN

EyePoint (EYPT) director adds to stake in open‑market buy

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

EyePoint, Inc. (EYPT) director Karen L. Zaderej reported an open-market or private purchase of 10,600 shares of Common Stock on 2026-08-18 at $4.93 per share. Following this transaction, she directly owns 49,100 shares of EyePoint, Inc. common stock. The Rule 10b5-1 trading plan checkbox was not marked, indicating the trade was not reported as made under such a plan.

Positive

  • None.

Negative

  • None.
Insider Zaderej Karen L.
Role Director
Bought 10,600 shs ($52K)
Type Security Shares Price Value
Purchase Common Stock 10,600 $4.93 $52K
Holdings After Transaction: Common Stock — 49,100 shares (Direct)
Shares purchased 10,600 shares Common Stock purchased on 2026-08-18
Purchase price per share $4.93 per share Price for Common Stock transaction on 2026-08-18
Shares owned after transaction 49,100 shares Direct ownership following the reported purchase
Common Stock financial
"The security acquired was <b>Common Stock</b> of EyePoint, Inc."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open market or private transaction financial
"Transaction code P denotes an <b>open market or private transaction</b>."
Rule 10b5-1 regulatory
"The Rule <b>10b5-1</b> trading plan checkbox was not marked."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did EYPT director Karen L. Zaderej report?

Karen L. Zaderej reported buying 10,600 shares of EyePoint, Inc. (EYPT) Common Stock. The purchase occurred on 2026-08-18 at a price of $4.93 per share in an open-market or private transaction.

At what price did Karen L. Zaderej buy EYPT shares?

She bought EyePoint, Inc. (EYPT) shares at $4.93 per share. The transaction involved 10,600 shares of Common Stock in an open-market or private purchase reported on 2026-08-18.

How many EYPT shares does Karen L. Zaderej own after this Form 4 transaction?

After the reported trade, Karen L. Zaderej directly owns 49,100 shares of EyePoint, Inc. (EYPT) Common Stock. This reflects her holdings immediately following the purchase of 10,600 shares on 2026-08-18.

Was Karen L. Zaderej’s EYPT share purchase under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox was not marked, so the reported EyePoint, Inc. (EYPT) purchase of 10,600 shares at $4.93 per share was not identified as made under a 10b5-1 trading plan.

What type of security did Karen L. Zaderej acquire in EyePoint, Inc. (EYPT)?

She acquired Common Stock of EyePoint, Inc. (EYPT). The Form 4 shows a purchase of 10,600 common shares at $4.93 per share, resulting in total direct ownership of 49,100 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zaderej Karen L.

(Last)(First)(Middle)
C/O EYEPOINT, INC.
480 PLEASANT STREET, SUITE C400

(Street)
WATERTOWN MASSACHUSETTS 02472

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/18/2026P10,600A$4.9349,100D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Ron Honig, Attorney-in-Fact08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)